Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuing vs Holding Metformin During Hospitalizations
NCT06296836Phase 4Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Jan 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by University of Illinois Chicago. Started Jan 2025; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06296836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06296836.